Physician profile
Ramon M Perez
NPI 1215132162
$7,679.70
in general payments reported to CMS, 2019-2025
14 companies · $393 in 2025
The $393 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $1,166 · 2021: $2,259 · 2022: $142 · 2023: $275 · 2024: $2,442 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748 · Travel and Lodging: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.06 |
| Travel and Lodging | $1,362.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $4,764.72 | 2019-2024 | |
| Arthrex, INC. | $1,712.07 | 2024 | Arthrex |
| Zimmer Biomet Holdings, INC. | $319.25 | 2021-2025 | Comprehensive, Persona, Rosa |
| Depuy Synthes Sales INC. | $251.68 | 2022-2025 | Na, Motoband, Speed Triad |
| Stryker Corporation | $162.66 | 2024-2025 | Mako, Inspace |
| Heron Therapeutics, INC. | $136.30 | 2021 | |
| Exactech, INC. | $119.25 | 2023 | |
| Alliance Medical | $65.00 | 2025 | |
| Bioventus LLC | $50.26 | 2021-2023 | Durolane |
| Medacta USA, INC. | $40.09 | 2020 | |
| Skeletal Dynamics INC | $21.81 | 2025 | Geminus, Ijs, Align |
| Smith+Nephew, INC. | $14.80 | 2019 | |
| Orthofix Medical, INC. | $14.72 | 2023 | Physio-Stim |
| Musculoskeletal Transplant Foundation INC. | $7.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.